HP
EW icon

HealthInvest Partners’s Edwards Lifesciences EW Stock Holding History

HealthInvest Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.34M Sell
103,230
-3,288
-3% -$275K 2.51% 17
2026
Q1 		$8.27M Buy
+106,518
New +$8.78M 2.67% 17
2025
Q4 		– Sell
-65,659
Closed -$542K – 40
2025
Q3 		$542K Buy
65,659
+8,299
+14% +$648K 2.01% 19
2025
Q2 		$4.49M Sell
57,360
-2,336
-4% -$174K 1.92% 19
2025
Q1 		$4.33M Sell
59,696
-8,600
-13% -$616K 1.91% 17
2024
Q4 		$5.07M Buy
68,296
+31,791
+87% +$2.23M 2.4% 14
2024
Q3 		$2.41M Hold
36,505
– – 1.13% 24
2024
Q2 		$3.37M Buy
36,505
+11,730
+47% +$1.04M 2.06% 13
2024
Q1 		$2.37M Buy
24,775
+3,960
+19% +$333K 1.44% 27
2023
Q4 		$1.59M Buy
+20,815
New +$1.45M 1.24% 23
2022
Q4 		$26.6K Buy
+356
New +$27.4K 0.05% 27

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

HealthInvest Partners's EW Position: Q2 2026 in Review

HealthInvest Partners reduced its Edwards Lifesciences (EW) stake by 3.1% in Q2 2026, selling an estimated $275K and leaving 103,230 shares worth $9.34M. The position accounts for 2.51% of the portfolio, ranked #17.

HealthInvest Partners first reported a position in EW in Q4 2022 and has held it in 11 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • HealthInvest Partners held 103,230 shares of Edwards Lifesciences worth $9.34M as of Q2 2026.
  • HealthInvest Partners sold 3,288 Edwards Lifesciences shares in Q2 2026, an estimated $275K.
  • Edwards Lifesciences made up 2.51% of HealthInvest Partners's portfolio in Q2 2026, its #17 holding.
  • HealthInvest Partners first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 11 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.